Efektivitas Antibiotik terhadap Parameter Klinis Pasien Pneumonia Pediatri di RSUD Bandung Kiwari
DOI:
https://doi.org/10.29313/bcsp.v6i2.25403Keywords:
Antibiotik, Pneumonia pediatri, EfektivitasAbstract
Abstract. Pneumonia is one of the leading causes of mortality and morbidity in children worldwide. The success of antibiotic therapy in patients with pneumonia is assessed not only by bacterial eradication but also by improvements in clinical parameters such as respiratory rate, oxygen saturation, and body temperature. This study aims to determine which antibiotics tend to be effective based on changes in these clinical parameters in pediatric pneumonia patients. The study used a descriptive observational design with a retrospective cross-sectional approach based on medical records of pediatric pneumonia patients who met the inclusion criteria. A total of 40 patients met the study criteria. All antibiotic regimens showed improvement in clinical parameters during the treatment period. The greatest reduction in respiratory rate was observed with the ceftriaxone regimen followed by azithromycin, with an average decrease of 17 breaths per minute. The greatest increase in oxygen saturation was achieved with the combination of cefotaxime and gentamicin, at 17%. The greatest reduction in body temperature occurred with the combination of levofloxacin and azithromycin, at 3.1°C. Nevertheless, cefotaxime monotherapy showed the most consistent trend of effectiveness across all clinical parameters, marked by a reduction in respiratory rate of 8.6 breaths/minute, an increase in oxygen saturation of 6.7%, and a reduction in body temperature of 2.0°C, Thus, it has the potential to be one of the effective regimens for the management of pediatric pneumonia; however, its use must still take the patient’s clinical condition into account.
Abstrak. Pneumonia merupakan salah satu penyebab mortalitas dan morbiditas pada anak di seluruh dunia. Keberhasilan terapi antibiotik pada pasien pneumonia tidak hanya dinilai dari eradikasi bakteri, tetapi juga melalui perbaikan parameter klinis seperti frekuensi napas, saturasi oksigen, dan suhu tubuh. Penelitian ini bertujuan untuk menentukan antibiotik yang cenderung efektif berdasarkan perubahan parameter klinis tersebut pada pasien pneumonia pediatri. Penelitian menggunakan desain deskriptif observasional dengan pendekatan potong lintang retrospektif berdasarkan data rekam medis pasien pneumonia pediatri yang memenuhi kriteria inklusi. Sebanyak 40 pasien memenuhi kriteria penelitian. Seluruh regimen antibiotik menunjukkan perbaikan parameter klinis selama masa perawatan. Penurunan frekuensi napas terbesar ditemukan pada regimen ceftriaxone yang dilanjutkan azitromisin dengan penurunan rata-rata sebesar 17 kali/menit. Peningkatan saturasi oksigen terbesar diperoleh pada kombinasi cefotaxime dan gentamisin sebesar 17%. Penurunan suhu tubuh terbesar terjadi pada kombinasi levofloxacin dan azitromisin sebesar 3,1°C. Meskipun demikian, cefotaxime monoterapi menunjukkan kecenderungan efektivitas yang paling konsisten pada seluruh parameter klinis, ditandai dengan penurunan frekuensi napas sebesar 8,6 kali/menit, peningkatan saturasi oksigen sebesar 6,7%, serta penurunan suhu tubuh sebesar 2,0°C, sehingga berpotensi menjadi salah satu regimen yang efektif dalam penatalaksanaan pneumonia pediatri, namun penggunaannya tetap perlu mempertimbangkan kondisi klinis pasien.
References
Furukawa, Y., Luo, Y., Funada, S., Onishi, A., Ostinelli, E., Hamza, T., Furukawa, T. A., & Kataoka, Y. (2023). Optimal duration of antibiotic treatment for community-acquired pneumonia in adults: A systematic review and duration-effect meta-analysis. BMJ Open, 13(3). https://doi.org/10.1136/bmjopen-2022-061023
Harris, L. K., & Crannage, A. J. (2021). Corticosteroids in Community-Acquired Pneumonia: A Review of Current Literature. In Journal of Pharmacy Technology (Vol. 37, Number 3, pp. 152–160). SAGE Publications Inc. https://doi.org/10.1177/8755122521995587
Ikatan Dokter Anak Indonesia. (2009). PEDOMAN NASIONAL PELAYANAN KEDOKTERAN (PNPK) TATA LAKSANA KASUS (Indonesian Pediatric Society ). http://slidepdf.com/reader/full/dody-firmanda-2013-usul-format-pnpk-dan-clinical-pathways-idai
Nurul, L., Rumah, S., Pertamedika, S., Rosnati, U., & Aceh, B. (2020). TINJAUAN PUSTAKA Pendekatan Diagnosis dan Tata Laksana Pneumonia pada Anak. Ked. N. Med |, 3(1).
Kemenkes RI. (2022). PROFIL KESEHATAN INDONESIA TAHUN 2021.
Kok, H. C., Chang, A. B., Fong, S. M., McCallum, G. B., Yerkovich, S. T., & Grimwood, K. (2025). Antibiotics for Paediatric Community-Acquired Pneumonia: What is the Optimal Course Duration? Pediatric Drugs, 27(3), 261–272. https://doi.org/10.1007/s40272-024-00680-4
Lorentzen, M. H., Rosenvinge, F. S., Lassen, A. T., Graumann, O., Laursen, C. B., Mogensen, C. B., & Skjøt-Arkil, H. (2023). Empirical antibiotic treatment for community-acquired pneumonia and accuracy for Legionella pneumophila , Mycoplasma pneumoniae, and Clamydophila pneumoniae: a descriptive cross-sectional study of adult patients in the emergency department. BMC Infectious Diseases, 23(1). https://doi.org/10.1186/s12879-023-08565-6
PAMKI. (2024). POLA PATOGEN DAN ANTIBIOGRAM DI INDONESIA TAHUN 2023.
Radjivshah, M. (2024). KARAKTERISTIK KLINIS PNEUMONIA PADA ANAK USIA 1 SAMPAI 5 TAHUN YANG DIRAWAT DI RSUD MEURAXA. In Jurnal Ilmu Kedokteran dan Kesehatan (Vol. 11, Number 11). http://ejurnalmalahayati.ac.id/index.php/kesehatan
Sakila Ersa Putri Hts, & Dika Amalia. (2023). BRONKOPNEUMONIA. Jurnal Medika Nusantara, 1(3), 134–145. https://doi.org/10.59680/medika.v1i3.403
UNICEF. (2019). For Every Child, Reimagine. UNICEF Annual Report 2019. (2020th ed., Vol. 2020). www.unicef.org/publications.
Wayan, N., Dewidika, J. M., Made, G., Surya, G., Trapika, C., Ayu, I., Widhiartini, A., Komang Satriyasa, B., & Korespondensi: I, P. (2025). Profil penggunaan antibiotik pada pasien Community Acquired Pneumonia (CAP) pediatri rawat inap di Rumah Sakit X Kabupaten Gianyar tahun 2023. Fakultas Kedokteran Universitas Udayana | Medicina, 56(1), 25–32. https://doi.org/10.15562/medicina.v56i1.1364
WHO. (2022). World Health Statistics 2022 : Monitoring Health for the SDGs, Sustainable Development Goals. World Health Organization.
WHO. (2023). World health statistics 2023: monitoring health for the SDGs, Sustainable Development Goals.
World Health Organization. (2020). WHO GUIDELINES ON PHYSICAL ACTIVITY AND SEDENTARY BEHAVIOUR.
Yang, A. S. H., Fan Chiang, H. Y., Tsai, D. H. Te, Chuang, A. T. M., & Lai, E. C. C. (2025). Association Between Pneumonia Risk and Anticholinergic Burden Among Patients with Different Frailty Levels. Clinical Epidemiology, 17, 787–796. https://doi.org/10.2147/CLEP.S524645
